Tacrolimus |
FK 506; Prograf |
Recent Blog Posts
View Post: Association Between Exposure to Topical Tacrolimus or Pimecrolimus ...
25 Nov 2009 by Hui, R. L, Lide, W., Chan, J., Schottinger,...
RESULTS: Age- and sex-adjusted hazard ratios for all cancers were 0.93 (95% CI 0.81 to 1.07; p = 0.306) for tacrolimus-exposed versus -unexposed subjects and 1.15 (95% CI 0.99 to 1.31; p = 0.054) for pimecrolimus-exposed versus ...
View Blog: Annals of Pharmacotherapy current issue - http://www.theannals.com/
View Post: Blood -- A phase II pilot study of tacrolimus/sirolimus GVHD ...
19 Nov 2009 by Rodriguez, R., Nakamura, R., Palmer, JM,...
Combination tacrolimus and sirolimus GVHD prophylaxis for allogeneic transplant in patients conditioned with a fractionated total body irradiation (TBI)-based regimen has shown encouraging results. We studied this prophylaxis ...
View Blog: BLOOD First Edition Papers - http://bloodjournal.hematologylibrary.org/
View Post: IP Pharma Doc: Tacrolimus (Prograf) 0.5 mg, 1mg and 5 mg capsules ...
12 Aug 2009 by Dr DK Sarwal
Generic player Sandoz has announced the introduction of Tacrolimus 0.5 mg, 1mg and 5 mg capsules, a generic equivalent of Prograf, in the US market. Tacrolimus is an immunosuppressive treatment used to help prevent rejection of a kidney ...
View Blog: IP Pharma Doc - http://ippharmdoc.blogspot.com/
View Post: Laser Therapy and Tacrolimus Ointment Best for Vitiligo
5 Oct 2009 by admin
Patients with vitiligo, a skin disease characterized by patches of un-pigmented skin, had better re-pigmentation of these patches when they were treated with a combination of laser therapy and tacrolimus ointment than the patients who ...
View Blog: People with Vitiligo - http://www.vitiligos.com/

Not Signed In -

